KEYTRUDA vs RESNIBEN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. KEYTRUDA and RESNIBEN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KEYTRUDA	RESNIBEN
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	PEMBROLIZUMAB	CABOZANTINIB
Manufacturer	Merck Sharp Dohme	Azurity
Dosage forms	Injectable	Tablet
Drug class	Programmed Death Receptor-1 Blocking Antibody	—
Boxed warning	None	None
Treats	Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms	Renal Cell Carcinoma

keytruda resniben

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

PEMBROLIZUMAB

CABOZANTINIB

Manufacturer

Merck Sharp Dohme

Azurity

Dosage forms

Injectable

Tablet

Drug class

Programmed Death Receptor-1 Blocking Antibody

—

Boxed warning

None

Treats

Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms

Renal Cell Carcinoma

Frequently asked questions

Which is better-rated, Keytruda or Resniben?

Keytruda and Resniben are tied at 3.5 out of 5 by our independent rating.

What is the difference between Keytruda and Resniben?

Keytruda contains Pembrolizumab, while Resniben contains Cabozantinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.